UroGen Pharma Ltd. IPO Research Information

UroGen Pharma Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on UroGen Pharma Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
UroGen Pharma Ltd.	URGN - NASDAQ	$12.00-$14.00	$13.00	$13.28	4.47 milliion	5/4/2017
Underwriter(s): Jefferies, Cowen and Company
Co-Manager(s): Raymond James, Oppenheimer & Co.
Industry: Health Care
Filing(s): Filed 2017-04-07 Terms Added 2017-04-24

UroGen Pharma Ltd. Quote & Chart - Click for current quote - URGN

About UroGen Pharma Ltd. (adapted from UroGen Pharma Ltd. prospectus):
They are a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "URGN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.